Ltr Pharma Fpo has released a press release.
SPONTAN Achieves Key Manufacturing Validation
Filed with ASX ·
6ix hasn’t read this filing yet.
Earlier from LTR Pharma
Later from LTR Pharma
- Recruitment commences for SPONTAN Clinical Study
- First patients dosed in SPONTAN pivotal study
- Final Patients dosed in SPONTAN pivotal study
- Response to ASX Price Query
- Suspension from Quotation
Follow LTR Pharma into a list and get an email when it puts out news.
Follow LTR Pharma